Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / COM
-
Number of holders
-
163
-
Total shares
-
53.4M
-
Shares change
-
+161K
-
Total reported value, excl. options
-
$1.34B
-
Value change
-
+$4.11M
-
Put/Call ratio
-
0.63
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$25.14
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2013
170 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q4 2013.
IMPAX LABORATORIES INC - COM (IPXL) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
.
Largest 10 shareholders include BlackRock Fund Advisors (4.79M shares), FMR LLC (4.54M shares), ORBIMED ADVISORS LLC (4.24M shares), VANGUARD GROUP INC (4.23M shares), RS INVESTMENT MANAGEMENT CO LLC (2.35M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.29M shares), BlackRock Institutional Trust Company, N.A. (1.89M shares), State Street Corp (1.89M shares), Ameriprise Financial Inc (1.62M shares), and RENAISSANCE TECHNOLOGIES LLC (1.41M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.